Details

Autor(en) / Beteiligte

• Ortiz-Vitali, Jose L.
• Wu, Jianbo
• Xu, Nasa
• Shieh, Annie W.
• Niknejad, Nima
• Takeuchi, Megumi
• Paradas, Carmen
• Lin, Chunru
• Jafar-Nejad, Hamed
• Haltiwanger, Robert S.
• Wang, Sidney H.
• Darabi, Radbod

Titel

Disease modeling and gene correction of LGMDR21 iPSCs elucidates the role of POGLUT1 in skeletal muscle maintenance, regeneration, and the satellite cell niche

Ist Teil von

• Molecular therapy. Nucleic acids, 2023-09, Vol.33, p.683-697

Ort / Verlag

Elsevier Inc

Erscheinungsjahr

2023

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• Autosomal recessive limb-girdle muscular dystrophy 21 (LGMDR21) is caused by pathogenic variants in protein O-glucosyltransferase 1 (POGLUT1), which is responsible for O-glucosylation of specific epidermal growth factor (EGF) repeats found in ∼50 mammalian proteins, including Notch receptors. Previous data from patient biopsies indicated that impaired Notch signaling, reduction of muscle stem cells, and accelerated differentiation are probably involved in disease etiopathology. Using patient induced pluripotent stem cells (iPSCs), their corrected isotypes, and control iPSCs, gene expression profiling indicated dysregulation of POGLUT1, NOTCH, muscle development, extracellular matrix (ECM), cell adhesion, and migration as involved pathways. They also exhibited reduced in vitro POGLUT1 enzymatic activity and NOTCH signaling as well as defective myogenesis, proliferation, migration and differentiation. Furthermore, in vivo studies demonstrated significant reductions in engraftment, muscle stem cell formation, PAX7 expression, and maintenance, along with an increased percentage of mislocalized PAX7+ cells in the interstitial space. Gene correction in patient iPSCs using CRISPR-Cas9 nickase led to the rescue of the main in vitro and in vivo phenotypes. These results demonstrate the efficacy of iPSCs and gene correction in disease modeling and rescue of the phenotypes and provide evidence of the involvement of muscle stem cell niche localization, PAX7 expression, and cell migration as possible mechanisms in LGMDR21. [Display omitted] Darabi and colleagues used iPSCs to study a new type of limb girdle muscular dystrophy (LGMDR21) for disease modeling and gene correction using CRIPSR-Cas9n. This study highlights the suitability of iPSCs to identify disease mechanisms and the efficacy of gene correction for reversing affected pathogenic mechanisms.